Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China flag China · Delayed Price · Currency is CNY
17.20
-0.34 (-1.94%)
May 12, 2026, 3:00 PM CST

SHA:603896 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
613.72628.6691.35770.34817.67759.99
Other Revenue
11.5811.5813.7614.0111.47.15
625.3640.18705.11784.35829.07767.14
Revenue Growth (YoY)
-5.27%-9.21%-10.10%-5.39%8.07%20.61%
Cost of Revenue
139.05136.55140.02135.53129.21126.37
Gross Profit
486.26503.63565.1648.82699.86640.76
Selling, General & Admin
352.48363.74397.84403.79405.17397.19
Research & Development
51.7151.6448.4149.6847.8250.82
Other Operating Expenses
16.022.6-2.15-4.526.847.67
Operating Expenses
420.07417.36443.73447.73461.41456.47
Operating Income
66.1886.27121.36201.09238.45184.3
Interest Expense
-28.07-24.21-14.93-24.7-13.03-10.17
Interest & Investment Income
18.4519.1436.8451.7729.9931
Other Non Operating Income (Expenses)
-4.92-0.61-1.1-0.43-0.68-0.56
EBT Excluding Unusual Items
51.6380.59142.18227.72254.73204.57
Gain (Loss) on Sale of Investments
8.117.784.630.27-1.26-12.33
Gain (Loss) on Sale of Assets
0.630.418.950.170.070.03
Asset Writedown
-0.01-0.01-0.02-0.03-0.06-0
Other Unusual Items
13.3613.3618.7426.7724.488.79
Pretax Income
73.72102.14174.48254.91277.97201.06
Income Tax Expense
85.3484.020.040.430.450.75
Earnings From Continuing Operations
-11.6218.12174.44254.48277.51200.31
Minority Interest in Earnings
0.060.05--0.270.52
Net Income
-11.5618.17174.44254.48277.78200.83
Net Income to Common
-11.5618.17174.44254.48277.78200.83
Net Income Growth
--89.58%-31.45%-8.39%38.32%32.37%
Shares Outstanding (Basic)
200202198196194191
Shares Outstanding (Diluted)
200202198196194191
Shares Change (YoY)
0.12%1.87%1.26%0.77%1.56%3.77%
EPS (Basic)
-0.060.090.881.301.431.05
EPS (Diluted)
-0.060.090.881.301.431.05
EPS Growth
--89.77%-32.31%-9.09%36.19%27.57%
Free Cash Flow
-65.87-45.15-292.1-99.48158.68135.07
Free Cash Flow Per Share
-0.33-0.22-1.47-0.510.820.71
Dividend Per Share
--0.2700.3900.4400.311
Dividend Growth
---30.77%-11.36%41.25%29.79%
Gross Margin
77.76%78.67%80.14%82.72%84.41%83.53%
Operating Margin
10.58%13.48%17.21%25.64%28.76%24.02%
Profit Margin
-1.85%2.84%24.74%32.45%33.51%26.18%
Free Cash Flow Margin
-10.53%-7.05%-41.43%-12.68%19.14%17.61%
EBITDA
142.39160.86189.5267.62295.78233.47
EBITDA Margin
22.77%25.13%26.88%34.12%35.68%30.43%
D&A For EBITDA
76.274.5968.1466.5357.3349.17
EBIT
66.1886.27121.36201.09238.45184.3
EBIT Margin
10.58%13.48%17.21%25.64%28.76%24.02%
Effective Tax Rate
115.76%82.26%0.03%0.17%0.16%0.37%
Revenue as Reported
625.3640.18705.11784.35829.07767.14
Advertising Expenses
-149.35190.63201.21201.3198.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.